Literature DB >> 27591296

Delays in Prior Living Kidney Donors Receiving Priority on the Transplant Waiting List.

Jennifer L Wainright1, David K Klassen2, Anna Y Kucheryavaya3, Darren E Stewart3.   

Abstract

BACKGROUND AND OBJECTIVES: Prior living donors (PLDs) receive very high priority on the Organ Procurement and Transplantation Network (OPTN) kidney waiting list. Program delays in adding PLDs to the waiting list, setting their status to active, and submitting requests for PLD priority can affect timely access to transplantation. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We used the OPTN and the Centers for Medicare and Medicaid Services data to examine timing of (1) listing relative to start of dialysis, (2) activation on the waiting list, and (3) requests for PLD priority relative to listing date. There were 210 PLDs (221 registrations) added to the OPTN kidney waiting list between January 1, 2010 and July 31, 2015.
RESULTS: As of September 4, 2015, 167 of the 210 PLDs received deceased donor transplants, six received living donor transplants, two died, five were too sick to transplant, and 29 were still waiting. Median waiting time to deceased donor transplant for PLDs was 98 days. Only 40.7% of 221 PLD registrations (n=90) were listed before they began dialysis; 68.3% were in inactive status for <90 days, 17.6% were in inactive status for 90-365 days, 8.6% were in inactive status for 1-2 years, and 5.4% were in inactive status for >2 years. Median time of PLDs waiting in active status before receiving PLD priority was 2 days (range =0-1450); 67.4% of PLDs received PLD priority within 7 days after activation, but 15.4% waited 8-30 days, 8.1% waited 1-3 months, 4.1% waited 3-12 months, and 5.0% waited >1 year in active status for PLD priority. After receiving priority, most were transplanted quickly. Median time in active status with PLD priority before deceased donor transplant was 23 days.
CONCLUSIONS: Fewer than one half of listed PLDs were listed before starting dialysis. Most listed PLDs are immediately set to active status and receive PLD priority quickly, but a substantial number spends time in active status without PLD priority or a large amount of time in inactive status, which affects access to timely transplants.
Copyright © 2016 by the American Society of Nephrology.

Entities:  

Keywords:  1-dodecylpyridoxal; Centers for Medicare and Medicaid Services (U.S.); Death; Living Donors; Transplants; United States; chronic kidney failure; kidney; kidney transplantation; living donors; renal dialysis

Mesh:

Year:  2016        PMID: 27591296      PMCID: PMC5108186          DOI: 10.2215/CJN.01360216

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  14 in total

1.  Perioperative Complications After Living Kidney Donation: A National Study.

Authors:  K L Lentine; N N Lam; D Axelrod; M A Schnitzler; A X Garg; H Xiao; N Dzebisashvili; J D Schold; D C Brennan; H Randall; E A King; D L Segev
Journal:  Am J Transplant       Date:  2016-03-10       Impact factor: 8.086

2.  Minimizing morbidity of organ donation: analysis of factors for perioperative complications after living-donor nephrectomy in the United States.

Authors:  Siddharth Patel; James Cassuto; Mark Orloff; Georgios Tsoulfas; Martin Zand; Randeep Kashyap; Ashok Jain; Adel Bozorgzadeh; Peter Abt
Journal:  Transplantation       Date:  2008-02-27       Impact factor: 4.939

3.  Hospitalizations following living donor nephrectomy in the United States.

Authors:  Jesse D Schold; David A Goldfarb; Laura D Buccini; James R Rodrigue; Didier Mandelbrot; Emily L G Heaphy; Richard A Fatica; Emilio D Poggio
Journal:  Clin J Am Soc Nephrol       Date:  2014-01-23       Impact factor: 8.237

4.  Morbidity and mortality in 1022 consecutive living donor nephrectomies: benefits of a living donor registry.

Authors:  Geir Mjøen; Ole Øyen; Hallvard Holdaas; Karsten Midtvedt; Pål-Dag Line
Journal:  Transplantation       Date:  2009-12-15       Impact factor: 4.939

5.  Kidney transplant outcomes for prior living organ donors.

Authors:  Vishnu Potluri; Meera N Harhay; F Perry Wilson; Roy D Bloom; Peter P Reese
Journal:  J Am Soc Nephrol       Date:  2014-11-20       Impact factor: 10.121

6.  Ethnic and gender related differences in the risk of end-stage renal disease after living kidney donation.

Authors:  W S Cherikh; C J Young; B F Kramer; S E Taranto; H B Randall; P-Y Fan
Journal:  Am J Transplant       Date:  2011-06-14       Impact factor: 8.086

7.  Perioperative mortality and long-term survival following live kidney donation.

Authors:  Dorry L Segev; Abimereki D Muzaale; Brian S Caffo; Shruti H Mehta; Andrew L Singer; Sarah E Taranto; Maureen A McBride; Robert A Montgomery
Journal:  JAMA       Date:  2010-03-10       Impact factor: 56.272

8.  Early clinical and economic outcomes of patients undergoing living donor nephrectomy in the United States.

Authors:  Amy L Friedman; Kevin Cheung; Sanziana A Roman; Julie Ann Sosa
Journal:  Arch Surg       Date:  2010-04

9.  Long-term risks for kidney donors.

Authors:  Geir Mjøen; Stein Hallan; Anders Hartmann; Aksel Foss; Karsten Midtvedt; Ole Øyen; Anna Reisæter; Per Pfeffer; Trond Jenssen; Torbjørn Leivestad; Pål-Dag Line; Magnus Øvrehus; Dag Olav Dale; Hege Pihlstrøm; Ingar Holme; Friedo W Dekker; Hallvard Holdaas
Journal:  Kidney Int       Date:  2013-11-27       Impact factor: 10.612

10.  Engaging Living Kidney Donors in a New Paradigm of Postdonation Care.

Authors:  K A Newell; R N Formica; J S Gill
Journal:  Am J Transplant       Date:  2015-12-07       Impact factor: 8.086

View more
  5 in total

1.  Ethical and Logistical Issues Raised by the Advanced Donation Program "Pay It Forward" Scheme.

Authors:  Lainie Friedman Ross; James R Rodrigue; Robert M Veatch
Journal:  J Med Philos       Date:  2017-10-01

2.  KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors.

Authors:  Krista L Lentine; Bertram L Kasiske; Andrew S Levey; Patricia L Adams; Josefina Alberú; Mohamed A Bakr; Lorenzo Gallon; Catherine A Garvey; Sandeep Guleria; Philip Kam-Tao Li; Dorry L Segev; Sandra J Taler; Kazunari Tanabe; Linda Wright; Martin G Zeier; Michael Cheung; Amit X Garg
Journal:  Transplantation       Date:  2017-08       Impact factor: 4.939

3.  Optimizing Decellularization Strategies for the Efficient Production of Whole Rat Kidney Scaffolds.

Authors:  Panagiotis Mallis; Charalampos Oikonomidis; Zetta Dimou; Catherine Stavropoulos-Giokas; Efstathios Michalopoulos; Michalis Katsimpoulas
Journal:  Tissue Eng Regen Med       Date:  2021-05-20       Impact factor: 4.169

4.  Mortality in Living Kidney Donors With ESRD: A Propensity Score Analysis Using the United States Renal Data System.

Authors:  Amarpali Brar; Dimitre G Stefanov; Rahul M Jindal; Moro O Salifu; Madhu Joshi; Bair Cadet; Robert Nee
Journal:  Kidney Int Rep       Date:  2018-04-19

5.  Lower Mortality in Living Kidney Donors With ESRD Versus Matched Nondonors With ESRD.

Authors:  Abimereki D Muzaale
Journal:  Kidney Int Rep       Date:  2018-07-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.